Sally Furniss
Well-known member
National Briefing with CDC: COVID-19 & Autoimmune Disease
Friday, April 3, 2020
-
FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website. -
We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.
National Briefing with CDC: COVID-19 & Autoimmune Disease
- Thread starter Sally Furniss
- Start date
National Briefing with CDC: COVID-19 & Autoimmune Disease
Friday, April 3, 2020
Sally Furniss
Well-known member
A few notes
Georgina Peacock (CDC)
Review of main symptoms of Covid-19
Review of basic hygiene and physical distancing
Immunocompromised potentially remain infectious longer ( this is seen with other viruses)
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020
The percentage of COVID-19 patients with at least one underlying health condition or risk factor was higher among those requiring intensive care unit (ICU) admission (358 of 457, 78%) and those requiring hospitalization without ICU admission (732 of 1,037, 71%) than that among those who were not hospitalized (1,388 of 5,143, 27%). The most commonly reported conditions were diabetes mellitus, chronic lung disease, and cardiovascular disease.
Of those hospitalised 3.7% were Immunocompromised
Aline Charabaty (24:00) Gastro-intestinal doctor
53% of Covid positive people shed virus in stool. This can persist for up to 5 weeks after the resolution of respiratory symptoms. Can last u pto 11 days after respiratory sample is negative
50% of hospitalized patients have GI symptoms (18% have diarrhea)
GI symptoms include loss of appetite, loss of taste, nausea, vomiting and diarrhea
For IBS, Crohn, Ulcerative colitis patients it’s important to try and distinguish between their flare symptoms and Covid. Such as do you have fever, respiratory symptoms?
Some patients have presented with acute colitis without fever or respiratory symptoms
Risk of a IBS patient getting covid infection is the same as the general population
Registry for IBD patients who have Covid (30)
Prednisone (31:35) High dosage >20mg increases the risk of complications from Covid
Nancy Carteron Rheumatologist (34:52) Special interest in patients with Sjogrens disease
Autoimmunity is generally organ specific or multi-organ specific
Database being developed for Covid-19 rheumatology patients
2 phases when exposed to virus
Initial viral replication phase. 80% of people will clear the virus.
In the second week or so it moves on to an inflammatory process which may be affected by immune disregulation. (from under lying conditions or medications)
Q and A
Some medications can mask symptoms such as fever. Have a high level of suspicion
Unknown when a vaccine will be available. Have to wait and see what the nature of the vaccine is to see if it is ok for patients with autoimmunity
Watching out for in the future
Can the second infection be worse. Can having certain antibodies make the second infection significantly worse
Georgina Peacock (CDC)
Review of main symptoms of Covid-19
Review of basic hygiene and physical distancing
Immunocompromised potentially remain infectious longer ( this is seen with other viruses)
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020
The percentage of COVID-19 patients with at least one underlying health condition or risk factor was higher among those requiring intensive care unit (ICU) admission (358 of 457, 78%) and those requiring hospitalization without ICU admission (732 of 1,037, 71%) than that among those who were not hospitalized (1,388 of 5,143, 27%). The most commonly reported conditions were diabetes mellitus, chronic lung disease, and cardiovascular disease.
Of those hospitalised 3.7% were Immunocompromised
Aline Charabaty (24:00) Gastro-intestinal doctor
53% of Covid positive people shed virus in stool. This can persist for up to 5 weeks after the resolution of respiratory symptoms. Can last u pto 11 days after respiratory sample is negative
50% of hospitalized patients have GI symptoms (18% have diarrhea)
GI symptoms include loss of appetite, loss of taste, nausea, vomiting and diarrhea
For IBS, Crohn, Ulcerative colitis patients it’s important to try and distinguish between their flare symptoms and Covid. Such as do you have fever, respiratory symptoms?
Some patients have presented with acute colitis without fever or respiratory symptoms
Risk of a IBS patient getting covid infection is the same as the general population
Registry for IBD patients who have Covid (30)
Prednisone (31:35) High dosage >20mg increases the risk of complications from Covid
Nancy Carteron Rheumatologist (34:52) Special interest in patients with Sjogrens disease
Autoimmunity is generally organ specific or multi-organ specific
Database being developed for Covid-19 rheumatology patients
2 phases when exposed to virus
Initial viral replication phase. 80% of people will clear the virus.
In the second week or so it moves on to an inflammatory process which may be affected by immune disregulation. (from under lying conditions or medications)
Q and A
Some medications can mask symptoms such as fever. Have a high level of suspicion
Unknown when a vaccine will be available. Have to wait and see what the nature of the vaccine is to see if it is ok for patients with autoimmunity
Watching out for in the future
Can the second infection be worse. Can having certain antibodies make the second infection significantly worse